Research Article

Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy

Table 3

Factors influencing early recurrence estimated by univariate and multivariate logistic regression.

Univariate regressionMultivariate regression
OR (95% CI)OR (95% CI)

GenderFemale0.868 (0.413, 1.825)0.7080.589 (0.231, 1.501)0.267
Male11

Age≤57 years old2.872 (1.330, 6.200)0.0073.049 (1.171, 7.941)0.022
>57 years old11

Tumor size (cm)≥50.963 (0.457, 2.032)0.9220.771 (0.305, 1.950)0.583
<511

Tumor locationLeft-sided colon1.067 (0.495, 2.299)0.8691.367 (0.468, 3.994)0.567
Right-sided colon11

Depth of tumor invasionT41.122 (0.455, 2.765)0.8031.242 (0.249, 6.193)0.791
T1 + T2 + T311

Lymph node metastasisN20.877 (0.427, 1.802)0.7221.207 (0.474, 3.077)0.740
N111

Histopathology gradePD0.687 (0.250, 1.882)0.4651.171 (0.462, 2.967)0.269
WD + MD11

Lymph-vascular invasionYes0.887 (0.413, 1.9070.7590.936 (0.355, 2.465)0.893
No11
Perineural invasionYes1.598 (0.774, 3.299)0.2050.651 (0.262, 1.619)0.356
No11

Prseoperative serum CEA level (ng/mL)≥51.970 (0.927, 4.186)0.0781.902 (0.688, 5.255)0.215
<511

Postoperative serum CEA level (ng/mL)≥52.514 (0.954, 6.627)0.0621.267 (0.325, 4.939)0.733
<511

Cycles of oxaliplatin-based regimen (cycles)≤85.925 (2.626, 13.371)<0.0014.995 (1.806, 13.815)0.002
>811

Pattern of recurrence/distant metastasisDistal metastasis1.328 (0.637, 2.771)0.4491.029 (0.395, 2.679)0.953
Local recurrence11

WD: well-differentiated; MD: moderately differentiated; PD: poorly differentiated; CEA: carcinoembryonic antigen.